<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Psychoactive Drugs</journal-id><journal-id journal-id-type="iso-abbrev">J Psychoactive Drugs</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Journal of psychoactive drugs</journal-title></journal-title-group><issn pub-type="ppub">0279-1072</issn><issn pub-type="epub">2159-9777</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6823125</article-id><article-id pub-id-type="pmcid-ver">PMC6823125.1</article-id><article-id pub-id-type="pmcaid">6823125</article-id><article-id pub-id-type="pmcaiid">6823125</article-id><article-id pub-id-type="manuscript-id">NIHMS1528963</article-id><article-id pub-id-type="pmid">31076020</article-id><article-id pub-id-type="doi">10.1080/02791072.2019.1612536</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1528963</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1528963</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Cohort alcohol use in France and the transition from use to alcohol use disorder and remission</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Husky</surname><given-names initials="MM">Mathilde M.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/00000153141403</contrib-id><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bharat</surname><given-names initials="C">Chrianna</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>L&#233;pine</surname><given-names initials="JP">Jean-Pierre</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kovess-Masfety</surname><given-names initials="V">Viviane</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib></contrib-group><aff id="A1"><label>1</label>Institut Universitaire de France, Universit&#233; de Bordeaux, Laboratoire de Psychologie EA4139, Bordeaux, France</aff><aff id="A2"><label>2</label>National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia</aff><aff id="A3"><label>3</label>Inserm UMR-S 1144, H&#244;pital Saint-Louis Lariboisi&#232;re Fernand Widal, Fernand-Widal, Paris, France</aff><aff id="A4"><label>4</label>Ecole des Hautes Etudes en Sant&#233; Publique, Institut de Psychologie de Paris Descartes (EA 4057), Paris, France</aff><author-notes><corresp id="CR1"><bold>Corresponding author:</bold> Mathilde Husky, Ph.D., Universit&#233; de Bordeaux, Institut Universitaire de France, Laboratoire de psychologie EA4139, 3 ter, place de la Victoire, 33076 Bordeaux, France, <email>mathilde.husky@u-bordeaux.fr</email>, tel :+33 608 -462-625.</corresp><fn fn-type="COI-statement" id="FN1"><p id="P29">Declaration of interest statement:</p><p id="P30">The authors declare no conflicts of interest.</p></fn></author-notes><pub-date pub-type="epub"><day>10</day><month>5</month><year>2019</year></pub-date><pub-date pub-type="ppub"><season>Nov-Dec</season><year>2019</year></pub-date><volume>51</volume><issue>5</issue><issue-id pub-id-type="pmc-issue-id">344785</issue-id><fpage>453</fpage><lpage>462</lpage><pub-history><event event-type="nihms-submitted"><date><day>12</day><month>05</month><year>2019</year></date></event><event event-type="pmc-release"><date><day>01</day><month>11</month><year>2020</year></date></event><event event-type="pmc-live"><date><day>01</day><month>11</month><year>2020</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-16 05:25:14.317"><day>16</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1528963.pdf"/><abstract id="ABS1"><p id="P1">The study aimed to examine the age of onset of stages of alcohol use in the general population, and to estimate the association of cohort use with the probability of transitioning from alcohol use to alcohol use disorder (AUD) and remission. French data (N=2,894) from the European Study of the Epidemiology of Mental Disorders Survey and collected in 2000 were used. Data on lifetime history of alcohol use and DSM-IV alcohol use disorders, and remission were collected. Nearly every adult has consumed alcohol at least once in their lifetime (92.8%), and among users, 88.3% developed regular use, 6.0% met criteria for abuse and 1.7% for dependence. One third of the population (32.8%) had used alcohol by the age of 15. Over 85% of cases of regular use were established prior to age 25, as were 61.1% of abuse and 39.4% of dependence cases. The proportion of people in an individual&#8217;s age and sex cohort who had already used alcohol by a given age was positively and significantly associated with increased odds of transitioning to each stage examined. The findings highlight sensitive periods of life where persons are at greater risk for transitioning to a higher level of alcohol use, and underscore the importance of cohort use in transition risk.</p></abstract><kwd-group><kwd>alcohol</kwd><kwd>abuse</kwd><kwd>cohort use</kwd><kwd>dependence</kwd><kwd>transition</kwd><kwd>remission</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>